BiotechTube
Home/PK MED/Julien Grassot, PhD
JG

Julien Grassot, PhD

Head of Biostatistics and Clinical Development

PK MED

Therapeutic Areas

RheumatologyHematologyMusculoskeletal Disorders

PK MED Pipeline

DrugIndicationPhase
PKM-01Gout FlarePhase 2
PKM-011OsteoarthritisPre-clinical
PKM-02Hemoglobinopathies (e.g., via HSCT enhancement)Pre-clinical

Leadership Team at PK MED

GP
Gauthier Pouliquen, PhD
Chief Executive Officer
VD
Vincent Dagommer
Chief Financial Officer
CS
Charles Sanson, PhD
Head of Research & Development
FM
Farah Marzouki, Eng., MSc
Head of Pharmaceutical Development
DP
Dr. Philippe Pouletty
Chairman of the Board
View full PK MED profile